102 On the other hand, a number of groups are advocating with the incorporation of novel markers, for instance a intricate karyotype55 or epigenetic subsets, 27,28 into clinical practice. Each one of these novel prognostic and/or predictive designs will should be validated in cohorts of individuals treated with qualified agents.Kingmaker make innov